Random-effects meta-analysis demonstrated higher salivary CRP levels in individuals with MetS compared with controls (SMD = 1.02; 95% CI -0.23 to 1.81), with substantial heterogeneity (I<sup>2</sup> = 98.91%), reflecting variation in population characteristics and saliva collection protocols. The gene discussed is CRP; the disease is metabolic syndrome.